Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 3 1

Status

Completed 2Unknown 1

Sponsor Class

NIH 3OTHER 2

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 3

Conditions

Lymphoma 43Breast Neoplasms 37Lymphoma, Large B-Cell, Diffuse 29Sarcoma 20Lymphoma, Non-Hodgkin 17Burkitt Lymphoma 16Neuroblastoma 15Leukemia 13HIV Infections 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Hodgkin Disease 11Acquired Immunodeficiency Syndrome 11Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9Ovarian Neoplasms 9Multiple Myeloma 9Carcinoma, Hepatocellular 9Lymphoma, Large-Cell, Immunoblastic 8Lymphoma, Follicular 8Liver Neoplasms 8Liposarcoma 7Breast Neoplasms, Male 7Lymphoma, Mantle-Cell 6Lymphoma, Large-Cell, Anaplastic 6Fallopian Tube Neoplasms 6Sarcoma, Kaposi 5Neoplasms, Plasma Cell 5Lymphoma, B-Cell 5Lung Neoplasms 5Histiocytoma, Malignant Fibrous 5Fibrosarcoma 5

Interventions

Irinotecan 15Gemcitabine 14Paclitaxel 13Cisplatin 13alvocidib 11Oxaliplatin 9Fluorouracil 9Taxes 7Leucovorin 7Carboplatin 7Bortezomib 73-aminopyridine-2-carboxaldehyde thiosemicarbazone 7tanespimycin 5Vorinostat 5Early Intervention, Educational 57-cyano-2,3,4,5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3-(phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine 4Topotecan 3Sorafenib 3Doxorubicin 3Docetaxel 3Capecitabine 3Bevacizumab 37-hydroxystaurosporine 3temsirolimus 2sargramostim 2ixabepilone 2eribulin 2aldesleukin 2VNP 20009 2Trastuzumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NIH × Unspecified Adult Solid Tumor, Protocol Specific × Doxorubicin × Clear all
NCT00005024 2014-01-06

Granisetron to Prevent Nausea and Vomiting After Chemotherapy in Patients With Malignant Disease

National Cancer Institute (NCI)

Phase 3 Unknown
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00331955 2013-07-02

Vorinostat and Doxorubicin in Treating Patients With Metastatic or Locally Advanced Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
40 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00079014 2013-05-16

3-AP and Doxorubicin In Treating Patients With Metastatic or Refractory Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
36 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡